PeterGSteinherzMD

Pediatric Hematology & Oncology • New York, NY

Pediatric Hematologic Oncology

Professor of Pediatrics, Cornell University-Weill Medical College

Overview of Dr. Steinherz

Dr. Peter Steinherz is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and New York-Presbyterian Hospital. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 49 years. He is one of 92 doctors at Memorial Sloan Kettering Cancer Center and one of 132 doctors at New York-Presbyterian Hospital who specialize in Pediatric Hematology & Oncology. He also speaks multiple languages, including Hungarian. He has more than 100 publications and over 500 citings.

Office
Memorial Sloan Kettering Cancer Center New York
1275 York Avenue
New York, NY 10021
Book by Phone+1(704) 512-0097
Is this information wrong?

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1973 - 1975
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 1969 - 1971
New York Presbyterian Hospital (Cornell Campus)Internship, Pediatrics, 1968 - 1969
Albert Einstein College of MedicineClass of 1968

Certifications & Licensure

NY State Medical License 1969 - 2026
NJ State Medical License 2020 - 2021
FL State Medical License 2017 - 2019
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2007-2020
America's Top Doctors for Cancer Castle Connolly, 2005-2020
New York Magazine: Top Doctors Castle Connolly, 2002-2020
America's Top Doctors Castle Connolly, 2002-2020
Super Doctor SuperDoctors.com
Fellow (FAAP) American Academy of Pediatrics
Join now to see all

Clinical Trials

Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Start of enrollment: 2004 Sep 04
Completed
Phase 3
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 22
Recruiting
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma Start of enrollment: 2007 Aug 06
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes Start of enrollment: 2007 Mar 01
Completed
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia Start of enrollment: 2007 Apr 01
Completed
Phase 1
Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma Start of enrollment: 2008 Feb 04
Active, not recruiting
Phase 3
Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA Start of enrollment: 1999 Sep 01
Completed
Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System Start of enrollment: 2008 Dec 08
Active, not recruiting
Phase 3
Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers Start of enrollment: 2008 Jun 02
Completed
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2008 Sep 15
Recruiting
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2009 Jan 01
Completed
Phase 2
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma Start of enrollment: 2010 Oct 01
Completed
Phase 2
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Join now to see all

Publications & Presentations

PubMed

2 citations
Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML.
Kavitha Ramaswamy, Peter G Steinherz, Anurag K Agrawal, Christopher J Forlenza, Audrey Mauguen, Mikhail Roshal, Tanya Trippett, Nancy A Kernan, Maria Luisa Sulis, Shuk...> ;Blood Advances. 2022 Apr 26
19 citations
Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic L...
Sanam Shahid, Kavitha Ramaswamy, Jessica Flynn, Audrey Mauguen, Karlo Perica, Jae H. Park, Christopher J. Forlenza, Peter G. Steinherz, Steven P. Margossian, Jaap Jan ...> ;Transplantation and Cellular Therapy. 2021 Nov 28
21 citations
11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.
, , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Cancer. 2020 Apr 22
146 citations
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
, , , , , , , , , , , , , , , , , , , , , , , , > ;Blood. 2019 Dec 26
7 citations
Treatment of higher risk acute lymphoblastic leukemia in young people (CCG-1961), long-term follow-up: a report from the Children's Oncology Group.
Peter G. Steinherz, Nita L. Seibel, Harland Sather, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Paul S. Gaynon> ;Leukemia. 2019 Feb 28
5 citations
Maintenance chemotherapy to reduce the risk of a metachronous Wilms tumor in children with bilateral nephroblastomatosis
Michael V. Ortiz, Shannon Fernandez-Ledon, Kavitha Ramaswamy, Christopher J. Forlenza, Rachel Kobos, Todd E. Heaton, Michael P. LaQuaglia, Peter G. Steinherz> ;Pediatric Blood & Cancer. 2019 Jan 1
5 citations
A case of KMT2A-SEPT9 fusion-associated acute megakaryoblastic leukemia.
Christopher J. Forlenza, Yanming Zhang, Jinjuan Yao, Ryma Benayed, Peter G. Steinherz, Kavitha Ramaswamy, Rachel Kessel, Mikhail Roshal> ;Cold Spring Harbor Molecular Case Studies. 2018 Dec 17
9 citations
Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Ketterin...
Lisa Giulino-Roth, Tara O'Donohue, Zhengming Chen, Tanya M. Trippett, Elizabeth Klein, Nancy A. Kernan, Rachel Kobos, Susan E. Prockop, Andromachi Scaradavou, Peter G....> ;Leukemia & Lymphoma. 2018 Aug 3
14 citations
Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia
Bartlomiej Getta, Mikhail Roshal, Junting Zheng, Jae H. Park, Eytan M. Stein, Ross L. Levine, Esperanza B. Papadopoulos, Ann A. Jakubowski, Nancy A. Kernan, Peter G. S...> ;Biology of Blood and Marrow Transplantation. 2017 Nov 1
4 citations
Vincristine toxicity with co-administration of fluconazole: Long-term concerns.
Jennifer Thackray, Krisoula Spatz, Peter G. Steinherz> ;Pediatric Blood & Cancer. 2017 May 24
101 citations
Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia
Sabine Topka, Joseph Vijai, Michael Walsh, Lauren Jacobs, Ann Maria, Danylo J. Villano, Pragna Gaddam, Gang Wu, Rose B. McGee, Emily Quinn, Hiroto Inaba, Christine Har...> ;Plos Genetics. 2015 Jun 23
183 citations
PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory H...
, , , , , , , , , , , , , , , , , , , , , , > ;The Lancet. Oncology. 2015 Mar 1
26 citations
ALK‐positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient
Melissa Pulitzer, Olakunle Ogunrinade, Oscar Lin, Peter G. Steinherz> ;Journal of Cutaneous Pathology. 2015 Mar 1
5 citations
High-dose cyclophosphamide for the treatment of refractory T-cell acute lymphoblastic leukemia in children.
Rachel Kobos, Thomas M. Renaud, Susan E. Prockop, Farid Boulad, Peter G. Steinherz> ;Journal of Pediatric Hematology/oncology. 2014 Jul 1
24 citations
Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia.
Rachel Kobos, Thomas M. Renaud, Laurel J. Steinherz, Peter G. Steinherz> ;Pediatric Blood & Cancer. 2014 Mar 1
28 citations
Ten‐year follow‐up of pediatric patients with non‐hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation
Lisa Giulino-Roth, Rosanna Ricafort, Nancy A. Kernan, Trudy N. Small, Tanya M. Trippett, Peter G. Steinherz, Susan E. Prockop, Andromachi Scaradavou, Michelle Chiu, Ri...> ;Pediatric Blood & Cancer. 2013 Dec 1
1508 citations
CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
Renier J. Brentjens, Marco L. Davila, Isabelle Riviere, Jae H. Park, Xiuyan Wang, Lindsay G. Cowell, Shirley Bartido, Jolanta Stefanski, Clare Taylor, Malgorzata Olsze...> ;Science Translational Medicine. 2013 Mar 20
113 citations
Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results fro...
Leonard A. Mattano, Meenakshi Devidas, James B. Nachman, Harland Sather, Stephen P. Hunger, Peter G. Steinherz, Paul S. Gaynon, Nita L. Seibel> ;The Lancet. Oncology. 2012 Sep 1
22 citations
Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab
Rachel Kobos, Thomas M. Renaud, Julie Teruya-Feldstein, Anita P. Price, Linda M. McAllister-Lucas, Peter G. Steinherz> ;Cancer. 2012 Aug 1
20 citations
Factors associated with relapse and survival in Wilms tumor: a multivariate analysis.
Joshua N. Honeyman, Barrie S. Rich, Maureen P. McEvoy, Molly A. Knowles, Glenn Heller, Edward Riachy, Rachel Kobos, Suzanne L. Wolden, Peter G. Steinherz, Michael P. L...> ;Journal of Pediatric Surgery. 2012 Jun 1
16 citations
Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia.
Rachel Kobos, Peter G. Steinherz, Nancy A. Kernan, Susan E. Prockop, Andromachi Scaradavou, Trudy N. Small, Ramzi Khalaf, Richard J. O'Reilly, Farid Boulad> ;Biology of Blood and Marrow Transplantation. 2012 Mar 1
23 citations
Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer
Peter L. Bonate, Casey Cunningham, Paul S. Gaynon, Sima Jeha, Richard Kadota, Gilbert N. Lam, Bassem I. Razzouk, Michael Rytting, Peter G. Steinherz, Steve Weitman> ;Cancer Chemotherapy and Pharmacology. 2011 Apr 1
99 citations
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
Nobuko Hijiya, Blythe Thomson, Michael S. Isakoff, Lewis B. Silverman, Peter G. Steinherz, Michael J. Borowitz, Richard Kadota, Todd M. Cooper, Violet Shen, Gary V. Da...> ;Blood. 2010 Nov 19
15 citations
Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia.
Peter G. Steinherz, Rachel Kobos, Laurel J. Steinherz> ;Pediatric Blood & Cancer. 2010 May 1
3 citations
Effect of hemodialysis on the plasma levels of clofarabine.
Peter G. Steinherz, Rachel Kobos, Sheron Latcha> ;Pediatric Blood & Cancer. 2010 Jul 15
Join now to see all

Lectures

Clofarabine with Topotecan, Vinorelbine, and Thiotepa (TVTC) in Children and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018